NICE is unable to make a recommendation about the use in the NHS of niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This is ...

NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This ...

Abiraterone acetate plus prednisone and enzalutamide improve overall survival (OS) and radiological progression-free survival (rPFS) in docetaxel-pretreated patients. Abiraterone acetate plus ...

ESMO 2024: Clinical Prognostic Factors Within the High-Volume Subgroup of Metastatic Hormone Sensitive Prostate Cancer in ENZAMET (ANZUP 1304) ESMO 2024: HARMONY: A Phase II Study of ...

The EMA’s human medicines committee has recommended approval for Akeega, a fixed-dose combination of J&J’s PARP drug Zejula (niraparib) and androgen inhibitor Zytiga (abiraterone acetate), in ...

daily (n = 37; age 40 years; LS T-score -2.4; hip T-score -1.7; average prednisone dose 8 mg for ... Medroxyprogesterone acetate; NSS: Not statistically significant; p.o.: Orally; QOD: Every ...

(15.8 mg/dL to 10.8 mg/dL). Calcium free acetate solution was sufficient to maintain serum calcium levels within the normal range.16 Dialysis may be regarded as salvage treatment of arrhythmia, ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

Treatment typically lasts for 5 days. Doctors may recommend oral prednisone (Prednisone Intensol and Rayos) in place of IV steroids, especially if you’re having a mild to moderate flare-up.